Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shankar, P.
Right arrow Articles by Lieberman, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shankar, P.
Right arrow Articles by Lieberman, J.
Related Collections
Right arrow Immunobiology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1 November 2000, Vol. 96, No. 9, pp. 3094-3101

IMMUNOBIOLOGY

Impaired function of circulating HIV-specific CD8+ T cells in chronic human immunodeficiency virus infection

Premlata Shankar, Melissa Russo, Brooke Harnisch, Mark Patterson, Paul Skolnik, and Judy Lieberman

From the Center for Blood Research, Harvard Medical School, and the New England Medical Center, Tufts University School of Medicine, Boston, MA.

The functional status of circulating human immunodeficiency (HIV)-specific CD8 T cells in chronically infected subjects was evaluated. By flow cytometry, only 5 of 7 subjects had detectable CD8 T cells that produced IFN-gamma after stimulation with HIV-infected primary CD4 T cells. In 2 subjects, the frequency of IFN-gamma -producing cells increased 4-fold when IL-2 was added to the culture medium; in another subject, IFN-gamma -producing cells could be detected only after IL-2 was added. IFN-gamma -producing cells ranged from 0.4% to 3% of CD8 T cells. Major histocompatibility complex-peptide tetramer staining, which identifies antigen-specific T cells irrespective of function, was used to evaluate the proportion of HIV-specific CD8 T cells that may be nonfunctional in vivo. CD8 T cells binding to tetramers complexed to HIV gag epitope SLYNTVATL and reverse transcriptase epitope YTAFTIPSI were identified in 9 of 15 and 5 of 12 HLA-A2-expressing seropositive subjects at frequencies of 0.1% to 1.1% and 0.1 to 0.7%, respectively. Freshly isolated tetramer-positive cells expressed a mixed pattern of memory and effector markers. On average, IFN-gamma was produced by less than 25% of tetramer-positive CD8 T cells after stimulation with the relevant gag or reverse transcriptase peptide. In all subjects tested, freshly isolated CD8 T cells were not cytolytic against peptide-pulsed B lymphoblastoid cell line or primary HIV-infected CD4 T-cell targets. Exposure to IL-2 enhanced the cytotoxicity of CD8 T cells against primary HIV-infected CD4 targets in 2 of 2 subjects tested. These results suggest that a significant proportion of HIV-specific CD8 T cells may be functionally compromised in vivo and that some function can be restored by exposure to IL-2.

© 2000 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
J. J. Chang, S. Sirivichayakul, A. Avihingsanon, A. J. V. Thompson, P. Revill, D. Iser, J. Slavin, S. Buranapraditkun, P. Marks, G. Matthews, et al.
Impaired Quality of the Hepatitis B Virus (HBV)-Specific T-Cell Response in Human Immunodeficiency Virus Type 1-HBV Coinfection
J. Virol., August 1, 2009; 83(15): 7649 - 7658.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. N. Blattman, E. J. Wherry, S.-J. Ha, R. G. van der Most, and R. Ahmed
Impact of Epitope Escape on PD-1 Expression and CD8 T-Cell Exhaustion during Chronic Infection
J. Virol., May 1, 2009; 83(9): 4386 - 4394.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. L. Ferre, P. W. Hunt, J. W. Critchfield, D. H. Young, M. M. Morris, J. C. Garcia, R. B. Pollard, H. F. Yee Jr, J. N. Martin, S. G. Deeks, et al.
Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control
Blood, April 23, 2009; 113(17): 3978 - 3989.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
R. B. Jones, L. C. Ndhlovu, J. D. Barbour, P. M. Sheth, A. R. Jha, B. R. Long, J. C. Wong, M. Satkunarajah, M. Schweneker, J. M. Chapman, et al.
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection
J. Exp. Med., November 24, 2008; 205(12): 2763 - 2779.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Caetano, A. Martinho, A. Paiva, B. Pais, C. Valente, and C. Luxo
Differences in Hepatitis C Virus (HCV)-Specific CD8 T-Cell Phenotype during Pegylated Alpha Interferon and Ribavirin Treatment Are Related to Response to Antiviral Therapy in Patients Chronically Infected with HCV
J. Virol., August 1, 2008; 82(15): 7567 - 7577.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Rehr, J. Cahenzli, A. Haas, D. A. Price, E. Gostick, M. Huber, U. Karrer, and A. Oxenius
Emergence of Polyfunctional CD8+ T Cells after Prolonged Suppression of Human Immunodeficiency Virus Replication by Antiretroviral Therapy
J. Virol., April 1, 2008; 82(7): 3391 - 3404.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Sen, W. A. Charini, R. A. Subbramanian, E. R. Manuel, M. J. Kuroda, P. A. Autissier, and N. L. Letvin
Clonal Focusing of Epitope-Specific CD8+ T Lymphocytes in Rhesus Monkeys following Vaccination and Simian-Human Immunodeficiency Virus Challenge
J. Virol., January 15, 2008; 82(2): 805 - 816.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Gupta, R. Boppana, G. C. Mishra, B. Saha, and D. Mitra
HIV-1 Tat Suppresses gp120-Specific T Cell Response in IL-10-Dependent Manner
J. Immunol., January 1, 2008; 180(1): 79 - 88.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Genesca, T. Rourke, J. Li, K. Bost, B. Chohan, M. B. McChesney, and C. J. Miller
Live Attenuated Lentivirus Infection Elicits Polyfunctional Simian Immunodeficiency Virus Gag-Specific CD8+ T Cells with Reduced Apoptotic Susceptibility in Rhesus Macaques that Control Virus Replication after Challenge with Pathogenic SIVmac239
J. Immunol., October 1, 2007; 179(7): 4732 - 4740.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J.-Y. Zhang, Z. Zhang, X. Wang, J.-L. Fu, J. Yao, Y. Jiao, L. Chen, H. Zhang, J. Wei, L. Jin, et al.
PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors
Blood, June 1, 2007; 109(11): 4671 - 4678.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. A. Ramsburg, J. M. Publicover, D. Coppock, and J. K. Rose
Requirement for CD4 T Cell Help in Maintenance of Memory CD8 T Cell Responses Is Epitope Dependent
J. Immunol., May 15, 2007; 178(10): 6350 - 6358.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Hryniewicz, D. A. Price, M. Moniuszko, A. Boasso, Y. Edghill-Spano, S. M. West, D. Venzon, M. Vaccari, W.-P. Tsai, E. Tryniszewska, et al.
Interleukin-15 but Not Interleukin-7 Abrogates Vaccine-Induced Decrease in Virus Level in Simian Immunodeficiency Virusmac251-Infected Macaques
J. Immunol., March 15, 2007; 178(6): 3492 - 3504.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Agnellini, P. Wolint, M. Rehr, J. Cahenzli, U. Karrer, and A. Oxenius
Impaired NFAT nuclear translocation results in split exhaustion of virus-specific CD8+ T cell functions during chronic viral infection
PNAS, March 13, 2007; 104(11): 4565 - 4570.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. L. Day, P. Kiepiela, A. J. Leslie, M. van der Stok, K. Nair, N. Ismail, I. Honeyborne, H. Crawford, H. M. Coovadia, P. J. R. Goulder, et al.
Proliferative Capacity of Epitope-Specific CD8 T-Cell Responses Is Inversely Related to Viral Load in Chronic Human Immunodeficiency Virus Type 1 Infection
J. Virol., January 1, 2007; 81(1): 434 - 438.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Hryniewicz, A. Boasso, Y. Edghill-Smith, M. Vaccari, D. Fuchs, D. Venzon, J. Nacsa, M. R. Betts, W.-P. Tsai, J.-M. Heraud, et al.
CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques
Blood, December 1, 2006; 108(12): 3834 - 3842.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Sun, J. E. Schmitz, A. P. Buzby, B. R. Barker, S. S. Rao, L. Xu, Z.-y. Yang, J. R. Mascola, G. J. Nabel, and N. L. Letvin
Virus-Specific Cellular Immune Correlates of Survival in Vaccinated Monkeys after Simian Immunodeficiency Virus Challenge
J. Virol., November 15, 2006; 80(22): 10950 - 10956.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. M. Acierno, J. E. Schmitz, D. A. Gorgone, Y. Sun, S. Santra, M. S. Seaman, M. H. Newberg, J. R. Mascola, G. J. Nabel, D. Panicali, et al.
Preservation of Functional Virus-Specific Memory CD8+ T Lymphocytes in Vaccinated, Simian Human Immunodeficiency Virus-Infected Rhesus Monkeys
J. Immunol., May 1, 2006; 176(9): 5338 - 5345.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. E. Snyder-Cappione, A. A. Divekar, G. M. Maupin, X. Jin, L. M. Demeter, and T. R. Mosmann
HIV-Specific Cytotoxic Cell Frequencies Measured Directly Ex Vivo by the Lysispot Assay Can Be Higher or Lower Than the Frequencies of IFN-{gamma}-Secreting Cells: Anti-HIV Cytotoxicity Is Not Generally Impaired Relative to Other Chronic Virus Responses
J. Immunol., February 15, 2006; 176(4): 2662 - 2668.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Elrefaei, B. Barugahare, F. Ssali, P. Mugyenyi, and H. Cao
HIV-Specific IL-10-Positive CD8+ T Cells Are Increased in Advanced Disease and Are Associated with Decreased HIV-Specific Cytolysis
J. Immunol., January 15, 2006; 176(2): 1274 - 1280.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. L. Janas, P. Groves, N. Kienzle, and A. Kelso
IL-2 Regulates Perforin and Granzyme Gene Expression in CD8+ T Cells Independently of Its Effects on Survival and Proliferation
J. Immunol., December 15, 2005; 175(12): 8003 - 8010.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. M. Allen, M. Altfeld, S. C. Geer, E. T. Kalife, C. Moore, K. M. O'Sullivan, I. DeSouza, M. E. Feeney, R. L. Eldridge, E. L. Maier, et al.
Selective Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 Evolution
J. Virol., November 1, 2005; 79(21): 13239 - 13249.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Lazarevic, D. Nolt, and J. L. Flynn
Long-Term Control of Mycobacterium tuberculosis Infection Is Mediated by Dynamic Immune Responses
J. Immunol., July 15, 2005; 175(2): 1107 - 1117.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Koibuchi, T. M. Allen, M. Lichterfeld, S. K. Mui, K. M. O'Sullivan, A. Trocha, S. A. Kalams, R. P. Johnson, and B. D. Walker
Limited Sequence Evolution within Persistently Targeted CD8 Epitopes in Chronic Human Immunodeficiency Virus Type 1 Infection
J. Virol., July 1, 2005; 79(13): 8171 - 8181.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Sundstrom, S. Ota, L. Y. Dimberg, M. G. Masucci, and A. Bergqvist
Hepatitis C Virus Core Protein Induces an Anergic State Characterized by Decreased Interleukin-2 Production and Perturbation of Mitogen-Activated Protein Kinase Responses
J. Virol., February 15, 2005; 79(4): 2230 - 2239.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. L. Mbisa, G. N. Nikolenko, and V. K. Pathak
Mutations in the RNase H Primer Grip Domain of Murine Leukemia Virus Reverse Transcriptase Decrease Efficiency and Accuracy of Plus-Strand DNA Transfer
J. Virol., January 1, 2005; 79(1): 419 - 427.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. F. Ochsenbein, S. R. Riddell, M. Brown, L. Corey, G. M. Baerlocher, P. M. Lansdorp, and P. D. Greenberg
CD27 Expression Promotes Long-Term Survival of Functional Effector-Memory CD8+ Cytotoxic T Lymphocytes in HIV-infected Patients
J. Exp. Med., December 6, 2004; 200(11): 1407 - 1417.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Dagarag, T. Evazyan, N. Rao, and R. B. Effros
Genetic Manipulation of Telomerase in HIV-Specific CD8+ T Cells: Enhanced Antiviral Functions Accompany the Increased Proliferative Potential and Telomere Length Stabilization
J. Immunol., November 15, 2004; 173(10): 6303 - 6311.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. Lichterfeld, D. E. Kaufmann, X. G. Yu, S. K. Mui, M. M. Addo, M. N. Johnston, D. Cohen, G. K. Robbins, E. Pae, G. Alter, et al.
Loss of HIV-1-specific CD8+ T Cell Proliferation after Acute HIV-1 Infection and Restoration by Vaccine-induced HIV-1-specific CD4+ T Cells
J. Exp. Med., September 20, 2004; 200(6): 701 - 712.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Lichterfeld, X. G. Yu, M. T. Waring, S. K. Mui, M. N. Johnston, D. Cohen, M. M. Addo, J. Zaunders, G. Alter, E. Pae, et al.
HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8+ T cells producing both interferon-{gamma} and tumor necrosis factor-{alpha}
Blood, July 15, 2004; 104(2): 487 - 494.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. L. Shacklett, C. A. Cox, M. F. Quigley, C. Kreis, N. H. Stollman, M. A. Jacobson, J. Andersson, J. K. Sandberg, and D. F. Nixon
Abundant Expression of Granzyme A, but Not Perforin, in Granules of CD8+ T Cells in GALT: Implications for Immune Control of HIV-1 Infection
J. Immunol., July 1, 2004; 173(1): 641 - 648.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. J. Wherry and R. Ahmed
Memory CD8 T-Cell Differentiation during Viral Infection
J. Virol., June 1, 2004; 78(11): 5535 - 5545.
[Full Text] [PDF]


Home page
J. Virol.Home page
J. M. Brenchley, B. J. Hill, D. R. Ambrozak, D. A. Price, F. J. Guenaga, J. P. Casazza, J. Kuruppu, J. Yazdani, S. A. Migueles, M. Connors, et al.
T-Cell Subsets That Harbor Human Immunodeficiency Virus (HIV) In Vivo: Implications for HIV Pathogenesis
J. Virol., February 1, 2004; 78(3): 1160 - 1168.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Draenert, C. L. Verrill, Y. Tang, T. M. Allen, A. G. Wurcel, M. Boczanowski, A. Lechner, A. Y. Kim, T. Suscovich, N. V. Brown, et al.
Persistent Recognition of Autologous Virus by High-Avidity CD8 T Cells in Chronic, Progressive Human Immunodeficiency Virus Type 1 Infection
J. Virol., January 15, 2004; 78(2): 630 - 641.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Abel, L. La Franco-Scheuch, T. Rourke, Z.-M. Ma, V. de Silva, B. Fallert, L. Beckett, T. A. Reinhart, and C. J. Miller
Gamma Interferon-Mediated Inflammation Is Associated with Lack of Protection from Intravaginal Simian Immunodeficiency Virus SIVmac239 Challenge in Simian-Human Immunodeficiency Virus 89.6-Immunized Rhesus Macaques
J. Virol., January 15, 2004; 78(2): 841 - 854.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Tsunetsugu-Yokota, Y. Morikawa, M. Isogai, A. Kawana-Tachikawa, T. Odawara, T. Nakamura, F. Grassi, B. Autran, and A. Iwamoto
Yeast-Derived Human Immunodeficiency Virus Type 1 p55gag Virus-Like Particles Activate Dendritic Cells (DCs) and Induce Perforin Expression in Gag-Specific CD8+ T Cells by Cross-Presentation of DCs
J. Virol., October 1, 2003; 77(19): 10250 - 10259.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. A. Migueles, A. C. Laborico, H. Imamichi, W. L. Shupert, C. Royce, M. McLaughlin, L. Ehler, J. Metcalf, S. Liu, C. W. Hallahan, et al.
The Differential Ability of HLA B*5701+ Long-Term Nonprogressors and Progressors To Restrict Human Immunodeficiency Virus Replication Is Not Caused by Loss of Recognition of Autologous Viral gag Sequences
J. Virol., June 15, 2003; 77(12): 6889 - 6898.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. J. Wherry, J. N. Blattman, K. Murali-Krishna, R. van der Most, and R. Ahmed
Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional Impairment
J. Virol., April 15, 2003; 77(8): 4911 - 4927.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Zhang, P. Shankar, Z. Xu, B. Harnisch, G. Chen, C. Lange, S. J. Lee, H. Valdez, M. M. Lederman, and J. Lieberman
Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic
Blood, January 1, 2003; 101(1): 226 - 235.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F. Buseyne, D. Scott-Algara, F. Porrot, B. Corre, N. Bellal, M. Burgard, C. Rouzioux, S. Blanche, and Y. Riviere
Frequencies of Ex Vivo-Activated Human Immunodeficiency Virus Type 1-Specific Gamma-Interferon-Producing CD8+ T Cells in Infected Children Correlate Positively with Plasma Viral Load
J. Virol., November 13, 2002; 76(24): 12414 - 12422.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Hel, J. Nacsa, E. Tryniszewska, W.-P. Tsai, R. W. Parks, D. C. Montefiori, B. K. Felber, J. Tartaglia, G. N. Pavlakis, and G. Franchini
Containment of Simian Immunodeficiency Virus Infection in Vaccinated Macaques: Correlation with the Magnitude of Virus-Specific Pre- and Postchallenge CD4+ and CD8+ T Cell Responses
J. Immunol., November 1, 2002; 169(9): 4778 - 4787.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Tryniszewska, J. Nacsa, M. G. Lewis, P. Silvera, D. Montefiori, D. Venzon, Z. Hel, R. W. Parks, M. Moniuszko, J. Tartaglia, et al.
Vaccination of Macaques with Long-Standing SIVmac251 Infection Lowers the Viral Set Point After Cessation of Antiretroviral Therapy
J. Immunol., November 1, 2002; 169(9): 5347 - 5357.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Wedemeyer, X.-S. He, M. Nascimbeni, A. R. Davis, H. B. Greenberg, J. H. Hoofnagle, T. J. Liang, H. Alter, and B. Rehermann
Impaired Effector Function of Hepatitis C Virus-Specific CD8+ T Cells in Chronic Hepatitis C Virus Infection
J. Immunol., September 15, 2002; 169(6): 3447 - 3458.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. E. Keir, M. G. Rosenberg, J. K. Sandberg, K. A. Jordan, A. Wiznia, D. F. Nixon, C. A. Stoddart, and J. M. McCune
Generation of CD3+CD8low Thymocytes in the HIV Type 1-Infected Thymus
J. Immunol., September 1, 2002; 169(5): 2788 - 2796.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. M. Agwale, M. T. Shata, M. S. Reitz Jr., V. S. Kalyanaraman, R. C. Gallo, M. Popovic, and D. M. Hone
A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice
PNAS, July 23, 2002; 99(15): 10037 - 10041.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Kostense, K. Vandenberghe, J. Joling, D. Van Baarle, N. Nanlohy, E. Manting, and F. Miedema
Persistent numbers of tetramer+ CD8+ T cells, but loss of interferon-gamma + HIV-specific T cells during progression to AIDS
Blood, April 1, 2002; 99(7): 2505 - 2511.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. M. Ortiz, J. Hu, J. A. Goldwitz, R. Chandwani, M. Larsson, N. Bhardwaj, S. Bonhoeffer, B. Ramratnam, L. Zhang, M. M. Markowitz, et al.
Residual Viral Replication during Antiretroviral Therapy Boosts Human Immunodeficiency Virus Type 1-Specific CD8+ T-Cell Responses in Subjects Treated Early after Infection
J. Virol., January 1, 2002; 76(1): 411 - 415.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Z. Hel, J. Nacsa, B. Kelsall, W.-P. Tsai, N. Letvin, R. W. Parks, E. Tryniszewska, L. Picker, M. G. Lewis, Y. Edghill-Smith, et al.
Impairment of Gag-Specific CD8+ T-Cell Function in Mucosal and Systemic Compartments of Simian Immunodeficiency Virus mac251- and Simian-Human Immunodeficiency Virus KU2-Infected Macaques
J. Virol., December 1, 2001; 75(23): 11483 - 11495.
[Abstract] [Full Text]


Home page
BloodHome page
J. Lieberman, P. Shankar, N. Manjunath, and J. Andersson
Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection
Blood, September 15, 2001; 98(6): 1667 - 1677.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Chen, P. Shankar, C. Lange, H. Valdez, P. R. Skolnik, L. Wu, N. Manjunath, and J. Lieberman
CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection
Blood, July 1, 2001; 98(1): 156 - 164.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
S. A. Ghanekar, L. E. Nomura, M. A. Suni, L. J. Picker, H. T. Maecker, and V. C. Maino
Gamma Interferon Expression in CD8+ T Cells Is a Marker for Circulating Cytotoxic T Lymphocytes That Recognize an HLA A2-Restricted Epitope of Human Cytomegalovirus Phosphoprotein pp65
Clin. Vaccine Immunol., May 1, 2001; 8(3): 628 - 631.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2000 by American Society of Hematology         Online ISSN: 1528-0020